Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Patsch

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Annals of the Rheumatic Diseases|April 26, 2007
Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosisE Aigner, I Schmid, C H Osterreicher, et al.
Journal of Internal Medicine|March 19, 2011
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasiaA Stadlmayr, E Aigner, B Steger, et al.
Transplantation Proceedings|August 1, 1987
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin)C M Ballantyne, P H Jones, C Payton-Ross, et al.
Journal of Lipid Research|June 1, 1996
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjectsP H Jones, H J Pownall, W Patsch, et al.
Nature Genetics|May 31, 2001
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humansH Esterbauer, C Schneitler, H Oberkofler, et al.
Clinical Chemistry|February 1, 1993
Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimensG R Warnick, G J Boerma, G Assmann, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2014
Gender- and site-specific differences of colorectal neoplasia relate to vitamin DE Aigner, A Stadlmayr, U Huber-Schönauer, et al.
Diabetes & Metabolism|September 30, 2018
Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approachA Feldman, S K Eder, T K Felder, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Annals of the Rheumatic Diseases|April 26, 2007
Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosisE Aigner, I Schmid, C H Osterreicher, et al.
Journal of Internal Medicine|March 19, 2011
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasiaA Stadlmayr, E Aigner, B Steger, et al.
Transplantation Proceedings|August 1, 1987
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin)C M Ballantyne, P H Jones, C Payton-Ross, et al.
Journal of Lipid Research|June 1, 1996
Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjectsP H Jones, H J Pownall, W Patsch, et al.
Nature Genetics|May 31, 2001
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humansH Esterbauer, C Schneitler, H Oberkofler, et al.
Clinical Chemistry|February 1, 1993
Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimensG R Warnick, G J Boerma, G Assmann, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2014
Gender- and site-specific differences of colorectal neoplasia relate to vitamin DE Aigner, A Stadlmayr, U Huber-Schönauer, et al.
Diabetes & Metabolism|September 30, 2018
Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approachA Feldman, S K Eder, T K Felder, et al.
Pageof 14